top of page
The Professional Network for Healthcare Experts
Dipharma acquires UK rare-disease medicines distributor LogixX Pharma
Dipharma Group has acquired longstanding UK partner LogixX Pharma, converting a decade-long rare-disease medicines distribution relationship into a directly owned British commercial operation.
nuaxia
2 days ago2 min read
Eli Lilly partners with Hims & Hers to expand access to Zepbound and Foundayo obesity medicines
Lilly's commercial partnership with Hims & Hers brings two FDA-approved obesity treatments into an integrated telehealth prescribing and delivery pathway, with published self-pay starting prices from $149 per month.
nuaxia
2 days ago2 min read
bottom of page